Found: 4
Select item for more details and to access through your institution.
Association between genetic variants and development of antibodies to infliximab: A cross-sectional study in Chinese patients with Crohn’s disease.
- Published in:
- Frontiers in Pharmacology, 2023, v. 13, p. 1, doi. 10.3389/fphar.2023.1096816
- By:
- Publication type:
- Article
Comparison of Target- and IgG-Enrichment Strategies to Measure Adalimumab Concentrations in Human Plasma Using an Immunocapture-Liquid Chromatography-High-Resolution Mass Spectrometry Platform.
- Published in:
- Annals of Laboratory Medicine, 2024, v. 44, n. 5, p. 463, doi. 10.3343/alm.2023.0468
- By:
- Publication type:
- Article
Dynamics and implications of anti-drug antibodies against adalimumab using ultra-sensitive and highly drug-tolerant assays.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1429544
- By:
- Publication type:
- Article
Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn's disease.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1430120
- By:
- Publication type:
- Article